PURPOSE: To describe a patient who developed Aureobasidium pullulans keratitis following refractive laser epithelial keratomileusis (LASEK). METHODS: A 52-year-old woman was referred to a tertiary care center 1 month after LASEK for treatment of a corneal ulcer that was unresponsive to conventional therapy. Mycology culture and fungal stain identified Aureobasidium as the infectious organism. RESULTS: The infection responded well to treatment with topical natamycin and systemic itraconazole. CONCLUSIONS: Treatment with topical natamycin and systemic itraconazole is effective against Aureobasidium pullulans keratitis.
PURPOSE: To describe a patient who developed Aureobasidium pullulans keratitis following refractive laser epithelial keratomileusis (LASEK). METHODS: A 52-year-old woman was referred to a tertiary care center 1 month after LASEK for treatment of a corneal ulcer that was unresponsive to conventional therapy. Mycology culture and fungal stain identified Aureobasidium as the infectious organism. RESULTS: The infection responded well to treatment with topical natamycin and systemic itraconazole. CONCLUSIONS: Treatment with topical natamycin and systemic itraconazole is effective against Aureobasidium pullulans keratitis.